Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Clinical Endocrinology|February 1, 2012
No clinically significant valvular regurgitation in long-term cabergoline treatment for prolactinomaIrene Halperin, Javier Aller, César Varela, et al.
The Journal of Clinical Endocrinology and Metabolism|October 24, 2009
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegalyIgnacio Bernabeu, Cristina Alvarez-Escolá, Celsa Quinteiro, et al.
Thyroid : Official Journal of the American Thyroid Association|November 1, 2016
APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular LesionsEsmeralda Castelblanco, Carles Zafon, Javier Maravall, et al.
Plos One|August 16, 2014
Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?Jordi L Reverter, Carmen Fajardo, Eugenia Resmini, et al.
European Journal of Endocrinology|October 6, 2012
Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analoguesJosep Oriola, Tomás Lucas, Irene Halperin, et al.
Revista Espanola De Salud Publica|November 16, 2020
[New care models for transgender people in the Spanish Health System: demands, controversies and reflections.]Esther Gómez-Gil, Isabel Esteva de Antonio, María Fernández Rodríguez, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2021
Glucocorticoid-induced Fingerprints on Visceral Adipose Tissue Transcriptome and EpigenomeGuillermo García-Eguren, Mar González-Ramírez, Pedro Vizán, et al.
Pituitary|April 7, 2012
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)Gemma Sesmilo, Sonia Gaztambide, Eva Venegas, et al.
Pageof 6